13D/13G Filings - Mark Lappe

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-26
4:16 pm
Purchase
2024-09-12 13D Inhibrx Biosciences, Inc.
INBX
Mark Lappe 925,413
6.400%
164,000increase
(+21.54%)
Filing
History
2024-06-03
8:43 pm
Purchase
2024-05-29 13D Inhibrx Biosciences, Inc.
INBX
Mark Lappe 761,413
5.260%
761,413increase
(New Position)
Filing
History
2024-02-14
4:16 pm
Purchase
2023-12-31 13G Inhibrx Biosciences, Inc.
INBX
Mark Lappe 3,184,508
6.700%
34,794increase
(+1.10%)
Filing
History
2021-02-12
4:19 pm
Purchase
2020-12-31 13G Inhibrx Biosciences, Inc.
INBX
Mark Lappe 3,149,714
8.400%
3,149,714increase
(New Position)
Filing
History